Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: United Kingdom Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20021
20034
20041
20054
20064
20075
20085
200911
20105
20114
20125
20133
20147
20156
20162
20173
20181
20194
20205
20216
20223
20232
20243
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57
Active, not recruiting26
Terminated13
Recruiting11
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Pfizer8
Ferring Pharmaceuticals7
European Organisation for Research and Treatment of Cancer - EORTC5
Merck Sharp & Dohme LLC5
University College, London5
Aragon Pharmaceuticals, Inc.4
Bristol-Myers Squibb4
Janssen Research & Development, LLC4
Sanofi4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms111
Neoplasm Metastasis13
Neoplasms11
Pain3
Breast Neoplasms2
Carcinoma, Ovarian Epithelial2
Colorectal Neoplasms2
Genital Neoplasms, Male2
Ovarian Neoplasms2
Recurrence2

Trials

Showing 1 to 25 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.